European mtDNA Variants Are Associated With Differential Responses to Cisplatin, an Anticancer Drug: Implications for Drug Resistance and Side Effects
Background: Cisplatin, a powerful antitumor agent, causes formation of DNA adducts, and activation of apoptotic pathways. Presently, cisplatin resistance develops in up to 70% of patients but the underlying molecular mechanism(s) are unclear and there are no markers to determine which patients will...
Main Authors: | Tej H. Patel, Lucas Norman, Steven Chang, Sina Abedi, Catherine Liu, Marilyn Chwa, Shari R. Atilano, Kunal Thaker, Stephanie Lu, S. Michal Jazwinski, Michael V. Miceli, Nitin Udar, Daniela Bota, M. Cristina Kenney |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00640/full |
Similar Items
-
Differential effects of cisplatin on cybrid cells with varying mitochondrial DNA haplogroups
by: Sina Abedi, et al.
Published: (2020-10-01) -
Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA
by: Kunal Thaker, et al.
Published: (2016-09-01) -
Mitochondrial DNA Haplogroup M7 Confers Disability in a Chinese Aging Population
by: Dayan Sun, et al.
Published: (2020-10-01) -
Creation of Cybrid Cultures Containing mtDNA Mutations m.12315G>A and m.1555G>A, Associated with Atherosclerosis
by: Margarita A. Sazonova, et al.
Published: (2019-09-01) -
Haplogroup J mitogenomes are the most sensitive to the pesticide rotenone: Relevance for human diseases
by: Daniela Strobbe, et al.
Published: (2018-06-01)